137 related articles for article (PubMed ID: 7699460)
41. Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.
Barrett JA; Joyal JL; Hillier SM; Maresca KP; Femia FJ; Kronauge JF; Boyd M; Mairs RJ; Babich JW
Cancer Biother Radiopharm; 2010 Jun; 25(3):299-308. PubMed ID: 20578835
[TBL] [Abstract][Full Text] [Related]
42. Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.
Strickland DK; Vaidyanathan G; Friedman HS; Zalutsky MR
J Neurooncol; 1995; 25(1):9-17. PubMed ID: 8523094
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
[TBL] [Abstract][Full Text] [Related]
44. FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPET.
Macfarlane DJ; Shulkin BL; Murphy K; Wolf GT
Eur J Nucl Med; 1995 Nov; 22(11):1347-50. PubMed ID: 8575489
[TBL] [Abstract][Full Text] [Related]
45. Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.
Vaidyanathan G; Friedman HS; Keir ST; Zalutsky MR
Br J Cancer; 1996 May; 73(10):1171-7. PubMed ID: 8630274
[TBL] [Abstract][Full Text] [Related]
46. PET hydroxyephedrine imaging of neuroblastoma.
Shulkin BL; Wieland DM; Baro ME; Ungar DR; Mitchell DS; Dole MG; Rawwas JB; Castle VP; Sisson JC; Hutchinson RJ
J Nucl Med; 1996 Jan; 37(1):16-21. PubMed ID: 8543986
[TBL] [Abstract][Full Text] [Related]
47. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.
Tobes MC; Jaques S; Wieland DM; Sisson JC
J Nucl Med; 1985 Aug; 26(8):897-907. PubMed ID: 3162008
[TBL] [Abstract][Full Text] [Related]
48. Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent.
Vaidyanathan G; Strickland DK; Zalutsky MR
Int J Cancer; 1994 Jun; 57(6):908-13. PubMed ID: 8206683
[TBL] [Abstract][Full Text] [Related]
49. Meta-[123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineage.
He Y; Das B; Baruchel S; Kumar P; Wiebe L; Reilly RM
Nucl Med Commun; 2004 Nov; 25(11):1125-30. PubMed ID: 15577592
[TBL] [Abstract][Full Text] [Related]
50. Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).
Lashford LS; Hancock JP; Kemshead JT
Int J Cancer; 1991 Jan; 47(1):105-9. PubMed ID: 1985865
[TBL] [Abstract][Full Text] [Related]
51. Dexmedetomidine does not interfere with meta-iodobenzylguanidine (MIBG) uptake at clinically relevant concentrations.
Batra V; Makvandi M; Zuppa AF; Patel N; Elias J; Pryma DA; Maris JM
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27654664
[TBL] [Abstract][Full Text] [Related]
52. Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
Armour A; Mairs RJ; Gaze MN; Wheldon TE
Br J Cancer; 1994 Sep; 70(3):445-8. PubMed ID: 8080728
[TBL] [Abstract][Full Text] [Related]
53. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells.
Montaldo PG; Raffaghello L; Guarnaccia F; Pistoia V; Garaventa A; Ponzoni M
Int J Cancer; 1996 Jul; 67(1):95-100. PubMed ID: 8690531
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model.
Vaidyanathan G; Friedman HS; Keir ST; Zalutsky MR
Nucl Med Biol; 1996 Aug; 23(6):851-6. PubMed ID: 8940730
[TBL] [Abstract][Full Text] [Related]
55. Disposition of radioiodinated benzylguanidines in perfused rabbit lung: pharmacokinetics and effect of an organo-gold complexed antineoplastic agent.
Weng WL; Lazo JS; Gillis CN; Pitt BR
J Pharmacol Exp Ther; 1990 Oct; 255(1):59-65. PubMed ID: 2213571
[TBL] [Abstract][Full Text] [Related]
56. Problem with mouse neuroblastoma for iodine-131 MIBG studies.
Aboul-Enein HY
J Nucl Med; 1987 Feb; 28(2):255-6. PubMed ID: 3806232
[No Abstract] [Full Text] [Related]
57. Effect of specific activity on neuroblastoma uptake of I-123-meta-iodobenzylguanidine in nude mice xenografted with SK-N-SH cells.
Farahati J; Coenen H; Dutschka K; Stuben G; Knuhmann K; Budach W; Kremens B; Reiners C
Oncol Rep; 1997; 4(2):363-6. PubMed ID: 21590060
[TBL] [Abstract][Full Text] [Related]
58. Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells.
Smets LA; Janssen M; Metwally E; Loesberg C
Biochem Pharmacol; 1990 Jun; 39(12):1959-64. PubMed ID: 2353937
[TBL] [Abstract][Full Text] [Related]
59. Release mechanisms of [125I]meta-iodobenzylguanidine in neuroblastoma cells: evidence of a carrier-mediated efflux.
Servidei T; Iavarone A; Lasorella A; Mastrangelo S; Riccardi R
Eur J Cancer; 1995; 31A(4):591-5. PubMed ID: 7576975
[TBL] [Abstract][Full Text] [Related]
60. No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Appl Radiat Isot; 2005 Mar; 62(3):435-40. PubMed ID: 15607920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
